Endonovo Therapeutics Provides Update on Variable

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Endonovo Therapeutics Provides Update on Variable Convertible Notes

LOS ANGELES, CA--(Marketwired - Jun 15, 2016) - Endonovo Therapeutics, Inc. ( OTCQB : ENDV ) ("Endonovo" or the "Company"), a developer of bioelectronic medicine and therapies, announced it has retired two variable conversion rate notes for $55,000 and $50,750 respectively, which the Company believes sets the stage for a new financing plan. Additionally, the Company announced it has received a temporary restraining order against Kodiak Capital, COR Clearing and BMA Securities barring their ability to trade, lend or hypothecate all the remaining shares under the Equity Purchase Agreement with Kodiak Capital, including 1.89 million freely traded shares and 215,000 "Commitment Shares" issued to Kodiak Capital.

Additionally, the Company is providing information regarding its convertible promissory note with Regal Consulting ("Regal" and the "Regal Note"), which was issued November 30, 2015 and recently disclosed in an 8-K filing. The Regal Note contains a Leak Out Provision allowing Regal to sell a maximum of 20% of the given volume in a given day and prevents Regal from making trades after 3:30 PM EST. Regal Consulting has assisted the Company with certain corporate awareness services, including management interviews, direct mail pieces to shareholders, follow up phone support with shareholders, and news articles on the Company providing significant value to shareholders.

When asked to comment, Alan Collier, the Company's Chairman and Chief Executive Officer, stated, "As a major requirement for securing the financing required to develop our bioelectronic medicine platform, we are working with our financial advisor to retire all variable convertible notes in order to preserve shareholder value and maintain confidence in our company. The Temporary Restraining Order allows us to preserve value by removing the 1.89 million shares from our publicly traded float while we continue to position the company for a larger round of institutional financing."

About Endonovo Therapeutics

Endonovo Therapeutics, Inc. is an innovative biotechnology company developing bioelectronic devices and therapies for regenerative medicine. Endonovo's Immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation, cell death and the promotion of regeneration. Endonovo's Cytotronics™ platform provides for a method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields (TVEMF) for tissue engineering and cell therapies. The Company's initial concentration is on the treatment of acute and chronic inflammatory conditions of the liver using its proprietary Immunotronics™ platform.

Investors: Sign Up for Email Alerts on Endonovo

Safe Harbor Statement

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

Investor Relations Contact: Endonovo Therapeutics, Inc. Mr. Steven Barnes Vice President of Investor Relations (800) 701-1223, Ext. 108 Sbarnes@endonovo.com www.endonovo.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 28

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 161

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 78

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 77

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 342

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 86

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 24

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 207

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Mercy Medical Center Nurses Mobilize for Patient Safety Picket

Updated Category News Views 35

Nurses Standing Together for Patient Safety Nurses at Mercy Medical Center are uniting for a cause that affects them profoundly: the safety of their patients and the workplace. With issues surrounding unsafe staffing and deteriorating care conditions, nurses represented by the Massachusetts Nurses Association plan to hold an informational picket. This demonstration is not...

Continue Reading
Massive Merger: Qorvo and Skyworks Unite for Future Innovations

Updated Category News Views 306

Overview of the Strategic Merger In an exciting development in the technology sector, shares of Qorvo, Inc. (NASDAQ: QRVO) and Skyworks Solutions, Inc. (NASDAQ: SWKS) are experiencing a notable surge after announcing their intent to merge. This deal, which values the combined entity at approximately $22 billion, marks a significant step forward in the realm of...

Continue Reading
Oryzon Genomics Announces Corporate Updates for September

Updated Category News Views 178

Oryzon Genomics to Share Updates on Corporate Progress Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a leading clinical-stage biopharmaceutical company dedicated to epigenetic therapies for critical medical needs, is set to present its latest corporate updates at several major international events. These important gatherings scheduled for September will showcase...

Continue Reading
Envision Energy Launches Innovative Energy Storage Solution

Updated Category News Views 363

Introducing the EN 8 Pro: A Revolution in Energy Storage Envision Energy, a leader in sustainable technology, has made a significant breakthrough in energy management with the launch of its EN 8 Pro 8MWh DC Liquid-Cooled Energy Storage System. This innovative setup is set to establish new industry standards in safety, efficiency, and environmental adaptability. Designed...

Continue Reading
Beard Papa's Teams Up for Exciting Zenless Zone Zero Launch

Updated Category News Views 528

Beard Papa's Exciting Flavor Collaboration Begins Beard Papa's, renowned for its delectable cream puffs and irresistible custard fillings, is thrilled to announce a nationwide collaboration with Zenless Zone Zero. This partnership will launch an exciting in-game event that will allow fans to experience the unique flavors inspired by the action-RPG sensation from...

Continue Reading